Loading chat...
FL S1092
Bill
Status
Engrossed
2/26/2026
Primary Sponsor
Appropriations Committee on Health and Human Services
Click for details
AI Summary
- Authorizes podiatric physicians to perform procedures using cellular or tissue-based products not approved by the FDA for connective tissue, ligament, and tendon repair, wound care, or pain management
- Requires cellular or tissue-based products to be retrieved, manufactured, and stored in FDA-registered facilities certified by organizations such as the American Association of Tissue Banks, and must contain viable cells verified by post-thaw analysis
- Mandates podiatric physicians include a prominent notice in all advertisements stating the products are not FDA-approved and encouraging patients to consult their primary care provider
- Requires signed informed consent forms detailing the treatment nature, FDA approval status, anticipated results, possible risks, and alternative treatments before performing procedures
- Establishes a third-degree felony for podiatric physicians who use human cells or tissues derived from aborted fetuses or embryos, or who sell products created using cellular or tissue-based products
Legislative Description
Podiatric Medicine
Last Action
CS passed; YEAS 112, NAYS 0
3/10/2026
Committee Referrals
Rules2/19/2026
Appropriations Subcommittee on Health and Human Services2/12/2026
Full Bill Text
No bill text available